2011International journal of pediatricsRequires access

Research development of leukotriene receptor antagonists as treatment for children with asthma

Hong Zhang, Yun Gao, Hongxia Zhao

Open publisher page 0 citations

Abstract

Leukotriene is a crucial inflammation medium in the process of asthma,involved in the inflammation and remodeling of airway.This article summarizes the origin,synthesis and biological activity of leukotriene in asthma.and discuss the implications of leukotriene receptor antagonists(Montelukast)for asthma in children.The randomized.double-blind and muhicenter clinical trials are needed to determine the efficacy of Montelukast in infants less than 2 years old with asthma. Key words: Asthma; Leukotriene; Leukotfiene receptor antagonists; Montelukast

About this research paper

What this paper is about

Leukotriene is a crucial inflammation medium in the process of asthma,involved in the inflammation and remodeling of airway.This article summarizes the origin,synthesis and biological activity of leukotriene in asthma.and discuss the implications of leukotriene receptor antagonists(Montelukast)for asthma in children.The randomized.double-blind and muhicenter clinical trials are needed to determine the efficacy of Montelukast in infants less than 2 years old with asthma. Key words: Asthma; Leukotriene; Leukotfiene receptor antagonists; Montelukast

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Leukotriene is a crucial inflammation medium in the process of asthma,involved in the inflammation and remodeling of airway.This article summarizes the origin,synthesis and biological activity of leukotriene in asthma.and discuss the implications of leukotriene receptor antagonists(Montelukast)for asthma in children.The randomized.double-blind and muhicenter clinical trials are needed to determine the efficacy of Montelukast in infants less than 2 years old with asthma. Key words: Asthma; Leukotriene; Leukotfiene receptor antagonists; Montelukast

Key concepts: Montelukast, Medicine, Asthma, Leukotriene receptor, Leukotriene, Leukotriene D4, Inflammation, Leukotriene E4

Related papers

Back to paper searchBrowse research topicsOriginal source
Research development of leukotriene receptor antagonists as treatment for children with asthma — Research Paper | ScholarLens